Research

If anyone can improve on Dexcom’s popular CGM design, it would be Google.

European and American regulators call for uniformity in insulin pump regulation. Part 1 in a multi-part series focused on pump safety.

Socioeconomics doesn’t explain it, researchers say.

Medtronic says it could give inaccurate bolus suggestions, and the FDA takes action on the device, which is only sold in Europe.

Researchers find a preliminary connection between a mother’s blood sugar levels and a child’s academic success.

The study will test whether a common blood pressure medication can stop Type 1 shortly after diagnosis.

A trio of young athletes and a distinguished coach make the case that CGMs are indispensable for many with Type 1.

A Swedish study finds biologic markers in young children that predicts a future Type 1 diagnosis.

New trial data shows it performs just as well as injectable glucagon, and even cuts the risk of nausea.

The Diabetes Research Connection steers crowdfunding to younger scientists with innovative ideas.

Researchers give the insulin to children at high risk of Type 1 to teach their immune systems not to overreact.

This Father’s Day, we celebrate dad-innovators who were inspired by their children’s Type 1 diagnosis to find new diabetes treatments.

Study finds an insulin and glucagon artificial pancreas outperforms an insulin-only artificial pancreas in staving off lows.

Ed Damiano, Aaron Kowalski, and others discuss how soon we are to having an artificial pancreas on the market.

A researcher argues at the ADA Scientific Sessions that patients need more than just pumps and CGMs to control blood glucose levels.

The new company hopes to bring an artificial pancreas to market using the infrastructure from recently-closed Asante.

Apple allows all iPhone users to become virtual trial participants.

A special ink, when drawn on the skin, can detect glucose in the bloodstream and determine blood sugar levels. (Sadly, not shown here.)

From predictive pumps to CGM data sharing, it’s been a good two months.

European testing will begin for the Mendor Smart, a device that uses cloud storage for blood glucose readings.